Evidence map›Paper›PMID 33384972›Full record

ReviewFrontiers in pediatrics2020

Vaccines for Perinatal and Congenital Infections-How Close Are We?

Tulika Singh, Claire E Otero, Katherine Li, Sarah M Valencia, Ashley N Nelson, Sallie R Permar

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Herpes zoster infection in pregnancy: features and consequences.Archives of dermatological research · 2024
    Review
  8. A review on Zika vaccine development.Pathogens and disease · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Maternal vaccination: a review of current evidence and recommendations.American journal of obstetrics and gynecology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tulika SinghDuke University Medical Center, Duke Human Vaccine Institute, Durham, NC, United States.
Claire E OteroDuke University Medical Center, Duke Human Vaccine Institute, Durham, NC, United States.
Katherine LiDuke University Medical Center, Duke Human Vaccine Institute, Durham, NC, United States.
Sarah M ValenciaDuke University Medical Center, Duke Human Vaccine Institute, Durham, NC, United States.
Ashley N NelsonDuke University Medical Center, Duke Human Vaccine Institute, Durham, NC, United States.
Sallie R PermarDuke University Medical Center, Duke Human Vaccine Institute, Durham, NC, United States.
Duke Medical Center · USDuke University · US

Funding

Virology CoreP01AI129859 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Cliburn C Chan · 2019 to 2026
$31.0M
The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcomeR21AI132677 · NIAID · DUKE UNIVERSITY · PI SWAMY, GEETA K. · 2018 to 2019
$399k
NIAID NIH HHS P01 AI129859NIAID NIH HHS R21 AI132677
6 · The paper itself

Abstract

Congenital and perinatal infections are transmitted from mother to infant during pregnancy across the placenta or during delivery. These infections not only cause pregnancy complications and still birth, but also result in an array of pediatric morbidities caused by physical deformities, neurodevelopmental delays, and impaired vision, mobility and hearing. Due to the burden of these conditions, congenital and perinatal infections may result in lifelong disability and profoundly impact an individual's ability to live to their fullest capacity. While there are vaccines to prevent congenital and perinatal rubella, varicella, and hepatitis B infections, many more are currently in development at various stages of progress. The spectrum of our efforts to understand and address these infections includes observational studies of natural history of disease, epidemiological evaluation of risk factors, immunogen design, preclinical research of protective immunity in animal models, and evaluation of promising candidates in vaccine trials. In this review we summarize this progress in vaccine development research for Cytomegalovirus, Group B Streptococcus, Herpes simplex virus, Human Immunodeficiency Virus, Toxoplasma, Syphilis, and Zika virus congenital and perinatal infections. We then synthesize this evidence to examine how close we are to developing a vaccine for these infections, and highlight areas where research is still needed.

Indexed as

child healthcongenital infectionsimmunology and infectious diseasesperinatal infectionsvaccines

Identifiers

PMID33384972
PMCPMC7769834
OpenAlexW3112593889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.